Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Angler - Who is the Brad that you continually speak of ?

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Jul 20, 2023 8:04am

173 Views

Post# 35549378

RE:RE:RE:RE:RE:RE:Angler - Who is the Brad that you continually speak of ?

Not always easy to be patient! The SP declining doesn't help. We all need to stay confident that the BOD are taking the right steps to get the best deal possible and of course it will probably not going to be fast enough! Added 2k shares in the 3.60s yesterday and hope that the decline stop today!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages